about
Ashkenazi Jews and breast cancer: the consequences of linking ethnic identity to genetic diseaseCommunication of genetic test results to family and health-care providers following disclosure of research results.A new HIV prevention network approach: sociometric peer change agent selection.Informatics technology mimics ecology: dense, mutualistic collaboration networks are associated with higher publication rates.How do women decide? Accepting or declining BRCA1/2 testing in a nationwide clinical sample in the United States.Aversion to ambiguity regarding medical tests and treatments: measurement, prevalence, and relationship to sociodemographic factors.Familial testicular cancer: interest in genetic testing among high-risk family members.Interest in genetic testing for modest changes in breast cancer risk: implications for SNP testing.What Black Women Know and Want to Know About Counseling and Testing for BRCA1/2Motivators for participation in a whole-genome sequencing study: implications for translational genomics research.Racial differences in attitudes toward innovative medical technologyGuidelines for genetic risk assessment of hereditary breast and ovarian cancer: early disagreements and low utilizationHealth Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast CancerCommunicating genetic risk information for common disorders in the era of genomic medicine.Cognitive biases and heuristics in medical decision making: a critical review using a systematic search strategy.Preferences for multigene panel testing for hereditary breast cancer risk among ethnically diverse BRCA-uninformative families.BRCA1/2 predictive testing: a study of uptake in two centresINNOVATORS AND EARLY ADOPTERS IN THE DIFFUSION OF INNOVATIONS: A LITERATURE REVIEW
P2860
Q24675652-38F81C33-7661-4539-BFA4-0195C9597B68Q33563539-446B6A53-FEB5-421E-9AE1-E8C16B703EEDQ33983957-1281BA4E-A5D6-485F-A158-96C845F777A1Q34141829-99BAE7D4-8939-439F-AD49-F03DCA81D458Q34231354-DCAD73DA-267B-4CCA-9CEA-C5DE81FE292BQ34381103-EB8E08B8-1B24-4DD1-A653-19AF5EB7B565Q34573358-827CA384-FE84-43B4-BAB0-5C681D844C0CQ35016127-089CD7A2-9BAF-400E-93D6-05AF75B06776Q35370858-AD8676F5-DFC0-4CDE-8C04-BC2E468BAC52Q35591689-5DDD48FB-C06A-48DE-A866-2A100F51AAD0Q35901359-4AB5FA5F-33CD-409B-A4DD-CA1056CED9E8Q37225176-875EBF16-B19A-4D91-A236-14F8D5BD510BQ37234825-C26303DF-7428-4DA5-A818-9E95B5798EC8Q37389775-ADA918CC-7D83-481D-A45B-3FA9A8DA97DFQ38242008-4A7022D2-CB62-4796-8FF7-DE1A6217ADB4Q47293243-1ECD14F0-1010-4A64-8906-004EF8F7E634Q57266761-60462DBD-11F1-48F3-9713-E042ACCCBE7CQ59239159-CAEF2EDA-26A6-424D-9F23-EA4C3533B5F7
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Early adoption of BRCA1/2 testing: who and why.
@en
type
label
Early adoption of BRCA1/2 testing: who and why.
@en
prefLabel
Early adoption of BRCA1/2 testing: who and why.
@en
P2860
P1433
P1476
Early adoption of BRCA1/2 testing: who and why.
@en
P2093
Barbara Weber
Katrina Armstrong
P2860
P356
10.1097/01.GIM.0000056829.76915.2A
P407
P577
2003-03-01T00:00:00Z